文献速递脑血管病

COVID-19与65岁及以上Medicare受益人急性缺血性卒中风险:自身对照病例系列研究

COVID-19 and Risk of Acute Ischemic Stroke Among Medicare Beneficiaries Aged 65 Years or Older: Self-Controlled Case Series Study.
PubMed 文献 · Neurology · 2022-02-03

本研究纳入2020年4月1日至2021年2月28日期间诊断为COVID-19的37,379例65岁及以上Medicare按服务收费受益人,采用自身对照病例系列设计分析COVID-19与急性缺血性卒中(AIS)的关联。结果显示,COVID-19诊断后0-3天AIS发病率比(IRR)为10.3(95%CI 9.86-10.8),4-7天为1.61(1.44-1.80),8-14天为1.44(1.32-1.57),15-28天为1.09(1.02-1.18);排除第0天病例后相应IRR分别为1.77(1.57-2.01)、1.60(1.43-1.79)、1.43(1.31-1.56)、1.09(1.01-1.17)。关联在较年轻受益人和无卒中史者中似乎更强。

要点

  • COVID-19诊断后0-3天AIS风险约为对照期的10倍(IRR 10.3,95%CI 9.86-10.8)。
  • 排除暴露当天病例后,第1-3天IRR为1.77(95%CI 1.57-2.01)。
  • 关联在65-74岁及无卒中史者中似乎更强。

核心结论

  • Medicare按服务收费受益人COVID-19诊断后前3天AIS风险约为对照期的10倍(风险期包含第0天病例时),关联在65-74岁及无卒中史者中似乎更强。
  • 本研究提供IV级证据表明SARS-CoV-2感染与65岁及以上Medicare按服务收费受益人诊断后前3天AIS风险增加相关。

研究设计与样本

  • 自身对照病例系列研究,纳入2020年4月1日至2021年2月28日诊断为COVID-19的37,379例65岁及以上Medicare按服务收费受益人,AIS住院时间为2019年1月1日至2021年2月28日。
  • 通过比较风险期(COVID-19诊断后0-3、4-7、8-14、15-28天)与对照期的AIS发病率,估计发病率比(IRR)。

主要发现

  • 37,379例COVID-19合并AIS的Medicare按服务收费受益人中,COVID-19诊断时中位年龄80.4岁(四分位距73.5-87.1),56.7%为女性。
  • 风险期包含暴露当天(第0天)时,COVID-19诊断后0-3、4-7、8-14、15-28天的IRR分别为10.3(95%CI 9.86-10.8)、1.61(1.44-1.80)、1.44(1.32-1.57)、1.09(1.02-1.18)。
  • 风险期排除第0天时,第1-3、4-7、8-14、15-28天的IRR分别为1.77(95%CI 1.57-2.01)、1.60(1.43-1.79)、1.43(1.31-1.56)、1.09(1.01-1.17)。
  • 关联在较年轻受益人和无卒中史者中似乎更强,在性别和种族/族裔间大体一致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Findings of association between coronavirus disease 2019 (COVID-19) and stroke remain inconsistent, ranging from significant association to absence of association to less than expected ischemic stroke among hospitalized patients with COVID-19. The current study examined the association between COVID-19 and risk of acute ischemic stroke (AIS). METHODS: We included 37,379 Medicare fee-for-service (FFS) beneficiaries aged ≥65 years diagnosed with COVID-19 from April 1, 2020, through February 28, 2021, and AIS hospitalization from January 1, 2019, through February 28, 2021. We used a self-controlled case series design to examine the association between COVID-19 and AIS and estimated the incidence rate ratios (IRRs) by comparing incidence of AIS in risk periods (0-3, 4-7, 8-14, 15-28 days after diagnosis of COVID-19) vs control periods. RESULTS: Among 37,379 Medicare FFS beneficiaries with COVID-19 and AIS, the median age at diagnosis of COVID-19 was 80.4 (interquartile range 73.5-87.1) years and 56.7% were women. When AIS at day of exposure (day = 0) was included in the risk periods, IRRs at 0-3, 4-7, 8-14, and 15-28 days following COVID-19 diagnosis were 10.3 (95% confidence interval 9.86-10.8), 1.61 (1.44-1.80), 1.44 (1.32-1.57), and 1.09 (1.02-1.18); when AIS at day 0 was excluded in the risk periods, the corresponding IRRs were 1.77 (1.57-2.01) (day 1-3), 1.60 (1.43-1.79), 1.43 (1.31-1.56), and 1.09 (1.01-1.17), respectively. The association appeared to be stronger among younger beneficiaries and among beneficiaries without prior history of stroke but largely consistent across sex and race/ethnicities. DISCUSSION: Risk of AIS among Medicare FFS beneficiaries was 10 times (day 0 cases in the risk period) as high during the first 3 days after diagnosis of COVID-19 as during the control period and the risk associated with COVID-19 appeared to be stronger among those aged 65-74 years and those without prior history of stroke. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased risk of AIS in the first 3 days after diagnosis in Medicare FFS beneficiaries ≥65 years of age.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Yang Q, Tong X, George MG, et al. COVID-19 and Risk of Acute Ischemic Stroke Among Medicare Beneficiaries Aged 65 Years or Older: Self-Controlled Case Series Study. Neurology. 2022. PMID: 35115387. doi:10.1212/WNL.0000000000013184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。